{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:43:29Z","timestamp":1761835409575,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2016R043-E04"],"award-info":[{"award-number":["2016R043-E04"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.tranon.2020.100855","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T16:25:34Z","timestamp":1600187134000},"page":"100855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of clinical molecular targets for childhood Burkitt lymphoma"],"prefix":"10.1016","volume":"13","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leijun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiyan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2020.100855_bb0005","unstructured":"National Cancer Institute. https:\/\/seer.cancer.gov\/. Accessed 15 October 2019."},{"issue":"2","key":"10.1016\/j.tranon.2020.100855_bb0010","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.tranon.2020.100855_bb0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/pbc.22383","article-title":"Trends in childhood cancer incidence and mortality in urban Shanghai, 1973\u20132005","volume":"54","author":"Bao","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"author":"American Cancer Society","key":"10.1016\/j.tranon.2020.100855_bb0020"},{"issue":"02","key":"10.1016\/j.tranon.2020.100855_bb0025","first-page":"148","article-title":"Chinese norms for the diagnosis and treatment of malignant lymphoma (2015 edition)","volume":"37","author":"Shi","year":"2015","journal-title":"Chinese Journal of Oncology."},{"issue":"10","key":"10.1016\/j.tranon.2020.100855_bb0030","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.tranon.2020.100855_bb0035","first-page":"605","article-title":"Clinical and prognostic analysis of 186 children with Burkitt's lymphoma","volume":"56","author":"Zhang","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi."},{"issue":"6","key":"10.1016\/j.tranon.2020.100855_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/08880018.2013.783891","article-title":"Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives","volume":"30","author":"Worch","year":"2013","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"23","key":"10.1016\/j.tranon.2020.100855_bb0045","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"7418","key":"10.1016\/j.tranon.2020.100855_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature."},{"issue":"9822","key":"10.1016\/j.tranon.2020.100855_bb0055","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2964(81)90060-8","article-title":"Variant translocation in a nonendemic case of Burkitt's lymphoma: t (8;22) in an Epstein-Barr virus negative tumour and in a derived cell line","volume":"17","author":"Bertrand","year":"1981","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2020.100855_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0165-4608(81)90039-X","article-title":"Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations","volume":"3","author":"Bernheim","year":"1981","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.tranon.2020.100855_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ijc.2910190408","article-title":"Chromosome 14 translocation in African and North American Burkitt's lymphoma","volume":"19","author":"Kaiser-McCaw","year":"1977","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2020.100855_bb0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.tranon.2020.100855_bb0080","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.3324\/haematol.2015.124305","article-title":"Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain\/loss pattern","volume":"100","author":"Ferreiro","year":"2015","journal-title":"Haematologica."},{"issue":"20","key":"10.1016\/j.tranon.2020.100855_bb0085","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.tranon.2020.100855_bb0090","unstructured":"NCCN Clinical Practice Guidelines in Oncology-Pediatric Aggressive Mature B-Cell Lymphomas (2020 Version 2)[DB\/OL]. http:\/\/www.nccn.org."},{"issue":"12","key":"10.1016\/j.tranon.2020.100855_bb0095","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.tranon.2020.100855_bb0100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.tranon.2020.100855_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic Burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"16","key":"10.1016\/j.tranon.2020.100855_bb0115","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.tranon.2020.100855_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood."},{"issue":"10","key":"10.1016\/j.tranon.2020.100855_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185563","article-title":"Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma","volume":"12","author":"Fan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2020.100855_bb0135","unstructured":"COSMIC. https:\/\/cancer.sanger.ac.uk\/cosmic. Accessed 26 May 2019."},{"key":"10.1016\/j.tranon.2020.100855_bb0140","unstructured":"Ensembl. http:\/\/grch37.ensembl.org\/index.html. Accessed 26 May 2019."},{"key":"10.1016\/j.tranon.2020.100855_bb0145","unstructured":"dbSNP. https:\/\/www.ncbi.nlm.nih.gov\/snp\/. Accessed 26 May 2019."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjc.2017.148","article-title":"Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia","volume":"117","author":"Chakrabarty","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.tranon.2020.100855_bb0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/pin.12333","article-title":"Low incidence of MYC\/BCL2 double-hit in Burkitt lymphoma","volume":"65","author":"Yoshida","year":"2015","journal-title":"Pathol. Int."},{"issue":"9","key":"10.1016\/j.tranon.2020.100855_bb0160","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3324\/haematol.2015.134510","article-title":"Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond","volume":"101","author":"Rosenquist","year":"2016","journal-title":"Haematologica."},{"issue":"3","key":"10.1016\/j.tranon.2020.100855_bb0165","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.13849","article-title":"The presence of genomic imbalances is associated with poor outcome in patients with Burkitt lymphoma treated with dose-intensive chemotherapy including rituximab","volume":"172","author":"Forero-Castro","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tranon.2020.100855_bb0170","unstructured":"My Cancer Genome. https:\/\/www.mycancergenome.org\/. Accessed 10 June 2019."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lrr.2012.10.002","article-title":"Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones","volume":"2","author":"Andersen","year":"2012","journal-title":"Leukemia Research Reports."},{"issue":"13","key":"10.1016\/j.tranon.2020.100855_bb0180","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.celrep.2018.03.019","article-title":"Repurposing pan-HDAC inhibitors for ARID1A-mutated ovarian cancer","volume":"22","author":"Fukumoto","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.tranon.2020.100855_bb0185","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/bjh.14604","article-title":"Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report","volume":"177","author":"Lee","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.tranon.2020.100855_bb0190","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.tranon.2020.100855_bb0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2020.100855_bb0200","unstructured":"ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/home. Accessed 30 May 2019."},{"issue":"4","key":"10.1016\/j.tranon.2020.100855_bb0205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/MOH.0000000000000059","article-title":"New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing","volume":"21","author":"Greenough","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.tranon.2020.100855_bb0210","doi-asserted-by":"crossref","unstructured":"Benezra R, Davis RL, Lassar A, Tapscott S, Thayer M, Lockshon D, et al. Id: a negative regulator of helix-loop-helix DNA binding proteins. control of terminal myogenic differentiation. Annals of the New York Academy of Sciences. 1990;599:1\u201311.","DOI":"10.1111\/j.1749-6632.1990.tb42359.x"},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(90)90214-Y","article-title":"The protein Id: a negative regulator of helix-loop-helix DNA binding proteins","volume":"61","author":"Benezra","year":"1990","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.tranon.2020.100855_bb0220","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ni1260","article-title":"Helix-loop-helix proteins and lymphocyte development","volume":"6","author":"Murre","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(03)00181-X","article-title":"A conserved transcriptional enhancer regulates RAG gene expression in developing B cells","volume":"19","author":"Hsu","year":"2003","journal-title":"Immunity."},{"issue":"10","key":"10.1016\/j.tranon.2020.100855_bb0230","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20090756","article-title":"Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci","volume":"206","author":"Beck","year":"2009","journal-title":"J. Exp. Med."},{"issue":"7277","key":"10.1016\/j.tranon.2020.100855_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/asheducation-2014.1.113","article-title":"Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis","volume":"2014","author":"Rossi","year":"2014","journal-title":"Hematology American Society of Hematology Education Program."},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0245","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia."},{"issue":"21","key":"10.1016\/j.tranon.2020.100855_bb0250","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1182\/blood.V124.21.5481.5481","article-title":"A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathways proteins","volume":"124","author":"Awasthi","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.tranon.2020.100855_bb0255","doi-asserted-by":"crossref","unstructured":"Aradhana Awasthi, Delphine C.M. Rolland, Janet Ayello, Carmella van de Ven, Venkatesha Basrur, Kevin Conlon, et al. A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment. Oncotarget. 2017;8(69):113895\u2013909.","DOI":"10.18632\/oncotarget.23040"},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41375-018-0188-8","article-title":"Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors","volume":"33","author":"Dwivedi","year":"2019","journal-title":"Leukemia."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41597-019-0015-8","article-title":"Phospho serine and threonine analysis of normal and mutated granulocyte colony stimulating factor receptors","volume":"6","author":"Dwivedi","year":"2019","journal-title":"Sci Data."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.1203103","article-title":"MyD88: a critical adaptor protein in innate immunity signal transduction","volume":"190","author":"Warner","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0275","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.immuni.2011.04.014","article-title":"The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock","volume":"34","author":"Mahabeleshwar","year":"2011","journal-title":"Immunity."},{"issue":"2","key":"10.1016\/j.tranon.2020.100855_bb0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/ATVBAHA.112.300619","article-title":"Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity","volume":"33","author":"Heo","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0285","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.ajpath.2013.01.029","article-title":"Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation","volume":"182","author":"Nayak","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.tranon.2020.100855_bb0290","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.0901798","article-title":"TLR2- and nucleotide-binding oligomerization domain 2-dependent Kruppel-like factor 2 expression downregulates NF-kappa B-related gene expression","volume":"185","author":"Zahlten","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/bjh.16147","article-title":"The impact of SOCS1 mutations in diffuse large B-cell lymphoma","volume":"187","author":"Mellert","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"6127","key":"10.1016\/j.tranon.2020.100855_bb0300","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.tranon.2020.100855_bb0305","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2141.2004.05107.x","article-title":"Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines","volume":"126","author":"Watanabe","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"7338","key":"10.1016\/j.tranon.2020.100855_bb0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523320303478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523320303478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:39:13Z","timestamp":1761835153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523320303478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1936523320303478"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2020.100855","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of clinical molecular targets for childhood Burkitt lymphoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2020.100855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100855"}}